🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Poly(ADP-ribose) polymerase (PARP) inhibitors are anti-cancer treatments th...
Status
Recruiting
Location
Centre Hospitalier Universitaire d'Amiens Picardie Site Sud
Start Date
2024-09-24
Trial ID
NCT06572735
Treatments Being Tested
This study seeks to understand the performance of MRI to characterize pancr...
Status
Enrolling By Invitation
Location
Cincinnati Children's Hospital Medical Center
Start Date
2023-01-18
Trial ID
NCT05659147
The purpose of this study is to learn how people with BRCA1/2 mutations res...
Status
Recruiting
Location
Memorial Sloan Kettering Cancer Center
Start Date
2025-09-25
Trial ID
NCT07197723
Treatments Being Tested
This randomized controlled trial aims to evaluate the impact of pre-test vi...
Status
Completed
Location
Dana-Farber Cancer Institute
Start Date
2017-11-21
Trial ID
NCT03328091
Treatments Being Tested
Most diagnostically unsolved rare disease have a genetic cause. These cause...
Status
Recruiting
Location
CHU de Dijon
Start Date
2019-11-14
Trial ID
NCT04024774
Treatments Being Tested
Cervical cancer as well cervical preneoplastic abnormalities (CIN2+) are ca...
Status
Completed
Location
Universidad de Antioquia
Start Date
2011-01
Trial ID
NCT02067468
Treatments Being Tested
Williams Syndrome (WS) is a rare neurodevelopmental disorder, usually cause...
Status
Not Yet Recruiting
Location
Qilu Hospital of Shandong University
Start Date
2026-04-01
Trial ID
NCT07509879
This study is a multicenter, prospective, randomized controlled Phase II cl...
Status
Not Yet Recruiting
Location
Beijing Cancer Hospital, 52 Fucheng Road
Start Date
2025-07-30
Trial ID
NCT06772233
Treatments Being Tested
This is a pilot study to improve rates of germline genetic testing for blac...
Status
Recruiting
Location
Henry Ford Cancer Pavilion
Start Date
2025-01-01
Trial ID
NCT05958082
Treatments Being Tested
The primary purpose of this study is to compare three interventions, two ex...
Status
Completed
Location
University of Michigan Rogel Cancer Center
Start Date
2022-04-21
Trial ID
NCT05162846